Novartis to buy BMS OTC brands for $660 million
Novartis is buying the U.S. and Canadian OTC business of Bristol-Myers Squibb for $660 million, giving the Swiss firm entry ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.